EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

An Online Cross-Sectional Research Domain Criteria (RDoC) Positive Valence Assessment Study With Patients With a Severe Mental Illness: Methodological Evaluation

Marit Broer, Marjolein E A Barendse, Laura van den Brink-Steinmann, Anne L Snijders, Marisha N Meijer, Sofie Paludanus, Monique van der Weijden-Germann, Robert M Bilder, Roel Ophoff, Neeltje E M van Haren

JMIR Formative Research · 2026-11-11 · 10 · e86998-e86998

DOI: 10.2196/86998 ↗
AstrattDettalji biblijografiċi

Astratt

Abstract Background Abnormal reward processing is considered a core feature of severe mental illness (SMI). Deficits in this domain can have severe implications for daily functioning. The Online Positive Valence Study aimed to assess reward processing in bipolar disorder and schizophrenia using the National Institute of Mental Health (NIMH) Research Domain Criteria (RDoC) Positive Valence Systems (PVS) framework in an online task-based study. Recruitment and study adherence fell short of expectations. Objective This paper critically evaluates the methodology used and shares the lessons learned from conducting an online task-based study of reward processing in a sample of patients with SMI. Methods Using a cross-sectional design, the Online Positive Valence Study measured reward processing using 3 reward tasks, the monetary incentive delay task (MID), effort expenditure of rewards task (EEfRT), and a social and coin version of the Bandit task. Participants were eligible if they were 18 years or older. They were recruited mainly via email from 2 completed prospective cohorts. From 2023, the initial recruitment goal was no longer followed. Recruitment strategies and task performance are evaluated. Results The sample consisted of 319 participants: 186 patients (58.3%), 81 first-degree relatives (25.4%), and 52 controls (16.3%). Multinomial logistic regression analyses revealed participants who were additionally called were more than 4 times more likely to respond “no” (odds ratio [OR] 4.57, 95% CI 3.12 to 6.70, P

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →